Area of presentation – Excipients - Functional capsule technologies based on Advanced Polymer Science
Frederique Bordes-Picard - Speaker Job Title: Director, Pharmaceutical Business Development Manager EMEA & India.
- What are the current global trends driving the pharmaceutical sector you are working in? How does your company respond to those trends?
The pharmaceutical industry is gradually recognizing excipients as being able to aid active pharmaceutical ingredients achieve better efficacy. The revolution from viewing excipients as inert agents to treating them as functional, active components has infused energy into this industry. At Capsugel, we have been building polymer science expertise for decades, and have brought a wide portfolio of specialized capsules able to address the needs of challenging drugs to the market.
2. What are the top challenges faced by the pharmaceutical sector you represent at this moment? How does your company deal with these challenges?
Within the pharmaceutical industry, the somehow stagnant R&D productivity, downward pricing pressure, and stringent regulations have all forced drug makers to increasingly turn to excipients to develop value-adding and differentiated products at the best cost without compromising on quality. Again, Capsugel is supporting customers through new specialized capsules combined with a range of innovative formulation strategies and well established dosage forms.
3. What topic are you presenting at the Pharma Insight Briefings and why is this subject so important to the market at this time?
Advancements in polymer science and, in particular, the application of hypromellose (HPMC) to capsules is expanding the role that encapsulation plays in drug delivery and formulation science. My presentation will look into the options available today to achieve immediate, delayed, or controlled, site-specific release.
4. What can attendees to your session expect to gain and which challenges does this content address? Why should they include your presentation in their agenda?
The presentation should be of high interest to any pharmaceutical development scientist or project manager working in the oral delivery field and interested to speed up development with sound QbD principles in mind. The advancement in polymer science and the expanded range of HPMC-based capsules makes it possible to address complex formulation challenges while providing readily available functional finished dosage forms for Proof of concept / First in Human studies.
5. How do you see your sector of the market evolving in the next 5 years?
Undoubtedly, the global pharmaceutical excipient market will continue to grow in the near future and the growth pattern will vary among different categories of excipients. The excipient industry will evolve closely along with the progress of the pharmaceutical industry as new active pharmaceutical ingredients are developed and novel drug delivery technologies are adopted. Following this trend, more innovative, multifunctional excipients can be expected to arrive in the market in the upcoming years.